Bedding manufacturer and retailer Sleep Number (NASDAQ: SNBR) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 7.8% year on year to $347.4 million. Its non-GAAP loss of $1.95 per share was significantly below analysts’ consensus estimates.

Is now the time to buy SNBR? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Sleep Number’s fourth quarter was marked by a notable beat on revenue expectations, despite ongoing top-line pressures. Management attributed sequential improvement to the successful rollout of its new Comfort mode mattress and a streamlined product lineup, which CEO Linda Findley described as “3.5x what we expected and nearly twice all the sales of all 3 C Series beds that this bed replaces.” Leadership also emphasized the impact of $185 million in annualized cost reductions, which contributed to stronger-than-expected adjusted EBITDA and improved operational efficiency.

Looking ahead, Sleep Number’s leadership is focused on accelerating revenue momentum through a fully refreshed mattress portfolio, expanded marketing initiatives, and strategic partnerships. CFO Amy O’Keefe highlighted the company’s intent to achieve “double-digit sales growth in the second half” as the new beds reach stores and digital channels. Management cautioned that early 2026 will see margin pressure due to clearance of legacy inventory, but expects profitability to improve as new products scale and cost-saving measures take full effect.

Key Insights from Management’s Remarks

Management credited Q4 performance to rapid execution on new product launches, aggressive cost reductions, and an overhaul of marketing strategy, while also highlighting liquidity and capital structure as ongoing priorities.

• Product portfolio reset: The launch of the Comfort mode mattress, priced under $1,600, was designed to expand Sleep Number’s reach to younger and value-conscious demographics. According to management, early sales far exceeded internal projections, and attach rates for accessories like adjustable bases and bedding were particularly strong.
• Cost structure overhaul: Leadership highlighted the removal of $185 million in annualized costs, with an additional $50 million in fixed cost reductions identified and underway. These savings are expected to support margin improvement as revenue stabilizes.
• Marketing and brand repositioning: Sleep Number rebuilt its marketing foundation, focusing on targeted digital and social campaigns and launching its first new commercial in over two years. The partnership with sports figure Travis Kelce is intended to boost brand consideration and attract premium customers.
• Store network optimization: The company reduced its store count from 640 to 600, prioritizing higher-volume locations and improving retail productivity. Management sees this as a step toward a leaner, more efficient retail footprint.
• Liquidity and capital structure: Recognizing continued liquidity constraints, Sleep Number engaged Guggenheim Securities to identify refinancing options and address inbound interest in its credit facility, aiming to improve financial flexibility and support ongoing transformation.

Drivers of Future Performance

Management’s outlook is shaped by the success of new product launches, a rebalanced marketing approach, and ongoing cost discipline, with near-term margin pressures and liquidity management as key watchpoints.

• Full portfolio rollout impact: The rollout of four additional new mattresses in late March is expected to drive sequential revenue improvement, especially as store resets are completed by mid-April. Management anticipates these offerings will broaden appeal and support higher average revenue per unit, though legacy inventory clearance will create short-term headwinds.
• Marketing strategy evolution: By shifting to evenly distributed marketing spend throughout the year, Sleep Number aims to avoid inefficiencies observed in previous quarters and maximize return on advertising investment, supporting sustained sales growth as new products gain traction.
• Cost savings and liquidity risks: With all $50 million of new fixed cost reductions already identified, management is focused on execution. However, persistent softness in demand and the need for further restructuring of the capital structure represent ongoing risks to profitability and free cash flow.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will watch (1) the adoption rate and sales mix shift tied to the new mattress portfolio, (2) the effectiveness of rebalanced marketing spend and the partnership with Travis Kelce in driving brand engagement, and (3) progress on cost reduction and liquidity initiatives, especially as refinancing efforts and operational restructuring unfold. Execution on these fronts will be critical to Sleep Number’s turnaround.

Sleep Number currently trades at $3.71, down from $4.58 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.